Digital health news, funding roundup in the prior week; July 18

With $150B already invested, VC is set to have another recording breaking year

With $150B already invested, VC is set to have another recording breaking year. There was $75 billion invested across an estimated 4,302 deals in the second quarter of this year; while the amount invested stayed the same quarter-to-quarter, the number of deals fell 4 percent. In all, this brings the total for the first half of the year to $150 billion invested across 8,406 deals. Another record breaking year for venture is all but guaranteed now: 2021 has already raised over 91 percent of the $164.3 billion raised in 2020, and seen 68 percent of the 12,362 deals. Read more

Mantra Health: Mental health startup for college students, Mantra Health, adds teletherapy services for bipolar I disorder. Mantra is able to integrate with their clients' University Health Services to make a collaborative model. Students with bipolar I will be able to tap into teletherapy for support. The tool will also offer ongoing screenings for symptoms in between appointments, and students can text telehealth providers with any questions, or share info with university health clinicians. Read more

Youper: Youper this week announced the results of a collaborative study with Stanford University which confirms the success of its AI Therapy for treatment of anxiety and depression. Validating that digital mental health interventions for anywhere, anytime therapy are effective for managing emotional distress, Youper users saw a decrease in anxiety by 24% and a decrease in depression by 19% in just two weeks and sustained at four weeks. The benchmark study was recently published in JMIR. Read more

Stemson Therapeutics: Stemson Therapeutics is a San Diego-based startup aiming to create a hair loss treatment that makes net-new hair follicles. Stemson Therapeutics has raised $15 million in Series A funding. DCVC led, and was joined by AbbVie Ventures and Genoa Ventures. Read more

Swift Medical: Swift Medical is a Toronto-based company whose software aims to streamline clinical and administrative wound care management workflows. Swift Medical has raised $35 million in Series B funding. Virgo Investment Group led the round, through one of its managed-investment funds. Earlier backers DCVC and BDC Capital’s Women-in-Tech Fund also joined the round, along with numerous others.  Read more

Castor: Castor is a Hoboken, N.J.-based clinical trial software. Castor has raised $45 million in Series B funding. Eight Roads Ventures and F-Prime Capital led the round, joined by Two Sigma Ventures and Inkef Capital. Read more

Entos: Entos is a San Diego-based developer of small-molecule therapeutics. Entos raised $53 million in Series A funding. Coatue led the round, joined by Catalio Capital Management. Read more

Ribon Therapeutics: Ribon Therapeutics is a Cambridge, Ma.-based clinical stage biotech focused on cancer and inflammation. Ribon Therapeutics has raised $65 million. Deerfield Management and U.S. Venture Partners led the round, joined by Avego BioScience Capital, GV, Monashee Investment Management, and Peregrine Ventures. Read more

Prime Medicine: Prime Medicine is a Cambridge, Ma.-based gene editing startup co-founded by biochemist David Liu. Prime Medicine has raised $200 million in Series B funding. The company is backed by Arch Venture Partners, F-Prime Capital, GV, Newpath Partners, Casdin Capital, Cormorant, Moore Strategic Ventures, PSP Investments, Redmile Group, Samsara BioCapital and T. Rowe Price. Read more 

Bayesian Health: Bayesian Health is a New York-based startup that's building models for sepsis detection, patient deterioration and bedsores. Bayesian Health has emerged from stealth mode with backing $15 million led by Andreessen Horowitz. Read more

Eucalyptus: Eucalyptus is a Sydney, Australia-based Telehealth platform. Eucalyptus has raised $22.3 million in Series B funding led by NewView Capital, with participation from earlier investors Blackbird Ventures and W23, and new investor AirTree Ventures. The company has now raised $32.8 million altogether. Read more

Mytonomy: Mytonomy is a Bethesda, Md.-based, healthcare-focused customer relationship management platform that aims to inspire consumer-internet-like user engagement by managing and delivering short form video content with integrated surveys and real-time communications. Mytonomy has raised $25 million in Series B funding led by Level Equity, which has taken a minority ownership stake in the company. Philips and Carilion Clinic also participated in the Series B. Read more

Kriya Therapeutics: Kriya Therapeutics is a Redwood City, Ca-based is a next-generation gene therapy company focused on designing and developing transformative new treatments. Kriya has raised $100 million from previous investors Foresite Capital and JDRF T1D Fund chipped in, with new investors Woodline Partners LP, CAM Capital, Hongkou and Alumni Ventures also participating.  Read more 

Hawthorne Effect: is a San Francisco-based clinical trial decentralization startup. Hawthorne Effect raised $20 million in Series A funding. Northpond Ventures led the round, joined by SignalFire and P5 Health Ventures. Read more 

If you are interested in being included in our funding roundup, submit your press release or blog post about your financing round to kristin@vator.tv. If you want a longer write-up, please do give us a couple of days heads up. If you'd like to be included in our Today's Entrepreneur column, please send me your Vator profile.

Image by VSRao from Pixabay